Home » Spectral Diagnostics Raises $14 Million, to Collaborate With BioMS
Spectral Diagnostics Raises $14 Million, to Collaborate With BioMS
Spectral Diagnostics Inc. and BioMS Medical Corp. announced that BioMS
Medical and a syndicate of investors have invested $14 million in Spectral Diagnostics to advance Toraymyxin, a treatment for severe sepsis, towards regulatory
approval and commercialization in the United States.
Forbes
Forbes
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May